Diagnóstico, tratamiento y prevención | 16 ABR 17


Información para no especialistas para el diagnóstico, tratamiento y prevención de la gripe
Autor/a: Sam Ghebrehewet, Peter MacPherson, Antonia Ho.  BMJ 2016;355:i6258
INDICE:  1. Página 1 | 2. Referencias bibliográficas
Referencias bibliográficas

Referencias bibliográficas: 

1 World Health Organization. Influenza (seasonal)—Fact sheet No 211. 2014. www.who.int/mediacentre/factsheets/fs211/en/.

2 Cromer D, van Hoek AJ, Jit M, Edmunds WJ, Fleming D, Miller E. The burden of influenza in England by age and clinical risk group: a statistical analysis to inform vaccine policy. J Infect 2014;68:363-71. doi:10.1016/j.jinf.2013.11.013 pmid:24291062.

3 World Health Organization. Global Influenza Surveillance and Response System (GISRS). 2016. www.who.int/influenza/gisrs_laboratory/en/.

4 World Health Organization. Influenza vaccine viruses and reagents. 2016. www.who.int/ influenza/vaccines/virus/en/.

5 Ferguson L, Eckard L, Epperson WB, et al. Influenza D virus infection in Mississippi beef cattle. Virology 2015;486:28-34. doi:10.1016/j.virol.2015.08.030 pmid:26386554.

6 Hause BM, Collin EA, Liu R, et al. Characterization of a novel influenza virus in cattle and Swine: proposal for a new genus in the Orthomyxoviridae family. MBio 2014;5:e00031-14. doi:10.1128/mBio.00031-14 pmid:24595369.

7 A revision of the system of nomenclature for influenza viruses: a WHO memorandum. Bull World Health Organ 1980;58:585-91.pmid:6969132.

8 Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev 1992;56:152-79.pmid:1579108.

9 Olson DR, Heffernan RT, Paladini M, Konty K, Weiss D, Mostashari F. Monitoring the impact of influenza by age: emergency department fever and respiratory complaint surveillance in New York City. PLoS Med 2007;4:e247. doi:10.1371/journal.pmed.0040247 pmid:17683196.

10 Kawai S, Nanri S, Ban E, et al. Influenza vaccination of schoolchildren and influenza outbreaks in a school. Clin Infect Dis 2011;53:130-6. doi:10.1093/cid/cir336 pmid: 21690619.

11 Matsuzaki Y, Sugawara K, Furuse Y, et al. Genetic Lineage and Reassortment of Influenza C Viruses Circulating between 1947 and 2014. J Virol 2016;90:8251-65. doi:10.1128/JVI. 00969-16 pmid:27384661.

12 Public Health England. PHE guidance on use of antiviral agents for the treatment and prophylaxis of seasonal influenza. Version 7.0. PHE, 2016.

13 Lam PP, Coleman BL, Green K, et al. Predictors of influenza among older adults in the emergency department. BMC Infect Dis 2016;16:615. doi:10.1186/s12879-016-1966-4 pmid:27793117.

14 Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J. Clinical signs and symptoms predicting influenza infection. Arch Intern Med 2000;160:3243-7. doi:10.1001/archinte. 160.21.3243 pmid:11088084.

15 Ohmit SE, Monto AS. Symptomatic predictors of influenza virus positivity in children during the influenza season. Clin Infect Dis 2006;43:564-8. doi:10.1086/506352 pmid:16886147.

16 Minodier L, Charrel RN, Ceccaldi PE, et al. Prevalence of gastrointestinal symptoms in patients with influenza, clinical significance, and pathophysiology of  human influenza viruses in faecal samples: what do we know?Virol J 2015;12:215. doi:10.1186/s12985-015-0448-4 pmid:26651485.

17 Lessler J, Reich NG, Brookmeyer R, Perl TM, Nelson KE, Cummings DA. Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis 2009;9:291-300. doi:10.1016/S1473-3099(09)70069-6 pmid:19393959.

18 Department of Health. Routes of transmission of the influenza virus: scientific evidence base review. DoH, 2011.

19 Killingley B, Greatorex J, Digard P, et al. The environmental deposition of influenza virus from patients infected with influenza A(H1N1)pdm09: Implications for infection prevention and control. J Infect Public Health 2016;9:278-88. doi:10.1016/j.jiph.2015.10.009 pmid:26653976.

20 Lau LLH, Cowling BJ, Fang VJ, et al. Viral shedding and clinical illness in naturally acquired influenza virus infections. J Infect Dis 2010;201:1509-16. doi:10.1086/652241 pmid:20377412.

21 National Institute for Health and Care Excellence. Clinical Knowledge Summaries:Influenza-seasonal. 2015. https://cks.nice.org.uk/influenza-seasonal.

22 National Institute for Health and Care Excellence. Amantadine, oseltamivir and zanamivir for the treatment of influenza (technology appraisal guidance 168). 2009. www.nice.org. uk/Guidance/ta168.

23 Public Health England. Chapter 19: Influenza. In: Immunisation Against Infectious Disease. 2013, updated 2015. www.gov.uk/government/uploads/system/uploads/attachment_data/file/456568/2904394_Green_Book_Chapter_19_v10_0.pdf

24 Viboud C, Alonso WJ, Simonsen L. Influenza in tropical regions. PLoS Med 2006;3:e89.doi:10.1371/journal.pmed.0030089 pmid:16509764.

25 Moura FE. Influenza in the tropics. Curr Opin Infect Dis 2010;23:415-20. doi:10.1097/QCO.0b013e32833cc955 pmid:20644472.

26 World Health Organization. Pandemic influenza preparedness and response. WHO, 2010.

27 Jefferson T, Jones MA, Doshi P, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev 2014;4:CD008965.pmid:24718923.

28 Muthuri SG, Venkatesan S, Myles PR, et al. PRIDE Consortium Investigators. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med 2014;2:395-404. doi:10.1016/S2213-2600(14)70041-4 pmid:24815805.

29 Zambon M. Developments in the treatment of severe influenza: lessons from the pandemic of 2009 and new prospects for therapy. Curr Opin Infect Dis 2014;27:560-5. doi:10.1097/QCO.0000000000000113 pmid:25333476.

30 Dobson J, Whitley RJ, Pocock S, Monto AS. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet 2015;385:1729-37. doi:10.1016/S0140-6736(14)62449-1 pmid:25640810.

31 Department of Health. Chief Medical Officer and Chief Pharmaceutical Officer: advice on using antiviral medicines: influenza season 2015 to 2016. DoH, 2016.

32 World Health Organization. WHO Guidelines for pharmacological management of pandemic influenza A(H1N1) 2009 and other influenza viruses. WHO, 2010.

33 Demicheli V, Jefferson T, Al-Ansary LA, Ferroni E, Rivetti A, Di Pietrantonj C. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2014;3:CD001269.pmid:24623315. 34 Kliner M, Keenan A, Sinclair D, Ghebrehewet S, Garner P. Influenza vaccination for healthcare workers in the UK: appraisal of systematic reviews and policy options. BMJ Open 2016;6:e012149. doi:10.1136/bmjopen-2016-012149 pmid:27625062.



Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024